Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
21.88
-0.13 (-0.59%)
At close: Jul 18, 2025, 4:00 PM
22.19
+0.31 (1.42%)
After-hours: Jul 18, 2025, 7:10 PM EDT
Genmab Stock Forecast
Stock Price Forecast
The 7 analysts that cover Genmab stock have a consensus rating of "Buy" and an average price target of $37.8, which forecasts a 72.76% increase in the stock price over the next year. The lowest target is $27 and the highest is $48.
Price Target: $37.8 (+72.76%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Genmab stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 3 | 4 | 4 | 4 | 4 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 9 | 9 | 9 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $45 → $46 | Strong Buy | Maintains | $45 → $46 | +110.24% | Jul 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 → $37 | Strong Buy | Reiterates | $50 → $37 | +69.10% | Apr 9, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +105.67% | Mar 11, 2025 |
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Mar 11, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $27 | Hold → Buy | Upgrades | $27 | +23.40% | Feb 13, 2025 |
Financial Forecast
Revenue This Year
25.33B
from 2.99B
Increased by 747.74%
Revenue Next Year
29.09B
from 25.33B
Increased by 14.81%
EPS This Year
106.15
from 16.85
Increased by 530.06%
EPS Next Year
127.16
from 106.15
Increased by 19.79%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.2B | 32.3B | 37.9B | ||
| Avg | 25.3B | 29.1B | 33.1B | ||
| Low | 22.6B | 26.0B | 28.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 808.5% | 27.5% | 30.4% | ||
| Avg | 747.7% | 14.8% | 13.8% | ||
| Low | 655.0% | 2.6% | -3.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 139.40 | 154.12 | 194.49 | ||
| Avg | 106.15 | 127.16 | 156.10 | ||
| Low | 81.78 | 94.71 | 114.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 727.4% | 45.2% | 52.9% | ||
| Avg | 530.1% | 19.8% | 22.8% | ||
| Low | 385.4% | -10.8% | -9.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.